RxDoctor Payments Data

Yana Etkin, MD

Vascular Surgery · New Hyde Park, NYNPI 1952698847

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 45.8% of the total. 2025 is the largest year on record at $81,372, more than ten times the $2,075 reported in 2019. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$138,303in general payments, 2019–2025

Across 241 payments — averaging $573.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$63K
  • Cook Incorporated$37K
  • Inari Medical, Inc.$15K
  • W. L. Gore & Associates, Inc.$12K
  • Cook Medical LLC$6K
  • Boston Scientific$1K
  • plus $4K from 12 others
$92,717in research payments, 2019–2025

Across 22 payments — averaging $4214.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$68K
  • Sonavex, Inc.$25K

What the payments were for

  • Consulting fees$61,97545%
  • Speaking & faculty fees$44,38032%
  • Travel & lodging$17,46013%
  • Food & beverage$14,48210%
  • Education$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$138,303 in reported general payments places this provider in the 90th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$213,000
Medicare patients
317
Services billed
964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban14$20,690
EliquisApixaban17$11,845
ClopidogrelClopidogrel Bisulfate20$214
Oxycodone Hcl12$17

Paid to pharmacies, not to this prescriber.

Other vascular surgery in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →